Abstract
BackgroundIdiopathic pulmonary fibrosis is the most devastating fibrotic diffuse parenchymal lung disease which remains refractory to pharmacological therapies. Therefore, novel treatments are urgently required. Protease-activated receptor (PAR)-1 is a G-protein-coupled...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have